Cancer Research Cell Death Mechanisms and Cancer Therapy  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 67, 6342, July 1, 2007. doi: 10.1158/0008-5472.CAN-07-0663
© 2007 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rebacz, B.
Right arrow Articles by Krämer, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rebacz, B.
Right arrow Articles by Krämer, A.

Experimental Therapeutics, Molecular Targets, and Chemical Biology

Identification of Griseofulvin as an Inhibitor of Centrosomal Clustering in a Phenotype-Based Screen

Blanka Rebacz1,2, Thomas O. Larsen3, Mads H. Clausen4, Mads H. Rønnest4, Harald Löffler1,2, Anthony D. Ho2 and Alwin Krämer1,2

1 Clinical Cooperation Unit for Molecular Hematology/Oncology, German Cancer Research Center (DKFZ) and 2 Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany; 3 Center for Microbial Biotechnology, BioCentrum and 4 Department of Chemistry, Technical University of Denmark, Copenhagen, Denmark

Requests for reprints: Alwin Krämer, Clinical Cooperation Unit for Molecular Hematology/Oncology, German Cancer Research Center (DKFZ) and Department of Internal Medicine V, University of Heidelberg, Im Neuenheimer Feld 581, 69120 Heidelberg, Germany. Phone: 49-6221-421440; Fax: 49-6221-421444; E-mail: a.kraemer{at}dkfz-heidelberg.de.

A major drawback of cancer chemotherapy is the lack of tumor-specific targets which would allow for the selective eradication of malignant cells without affecting healthy tissues. In contrast with normal cells, most tumor cells contain multiple centrosomes, associated with the formation of multipolar mitotic spindles and chromosome segregation defects. Many tumor cells regain mitotic stability after clonal selection by the coalescence of multiple centrosomes into two functional spindle poles. To overcome the limitations of current cancer treatments, we have developed a cell-based screening strategy to identify small molecules that inhibit centrosomal clustering and thus force tumor cells with supernumerary centrosomes to undergo multipolar mitoses, and subsequently, apoptosis. Using a chemotaxonomic selection of fungi from a large culture collection, a relatively small but diverse natural product extract library was generated. Screening of this compound library led to the identification of griseofulvin, which induced multipolar spindles by inhibition of centrosome coalescence, mitotic arrest, and subsequent cell death in tumor cell lines but not in diploid fibroblasts and keratinocytes with a normal centrosome content. The inhibition of centrosome clustering by griseofulvin was not restricted to mitotic cells but did occur during interphase as well. Whereas the formation of multipolar spindles was dynein-independent, depolymerization of interphase microtubules seemed to be mechanistically involved in centrosomal declustering. In summary, by taking advantage of the tumor-specific phenotype of centrosomal clustering, we have developed a screening strategy that might lead to the identification of drugs which selectively target tumor cells and spare healthy tissues. [Cancer Res 2007;67(13):6342–50]




This article has been cited by other articles:


Home page
JCBHome page
A. Tibelius, J. Marhold, H. Zentgraf, C. E. Heilig, H. Neitzel, B. Ducommun, A. Rauch, A. D. Ho, J. Bartek, and A. Kramer
Microcephalin and pericentrin regulate mitotic entry via centrosome-associated Chk1
J. Cell Biol., June 29, 2009; 185(7): 1149 - 1157.
[Abstract] [Full Text] [PDF]


Home page
ASH ANNUAL MEETING ABSTRACTSHome page
M. S Raab, I. Breitkreutz, B. Rebacz, T. Nguyen, P. J. Hayden, M. H Clausen, T. O. Larsen, J. Fruehauf, K. C. Anderson, and A. Kraemer
GF-15, a Novel Inhibitor of Centrosomal Clustering, Suppresses Tumor Growth in Vivo.
Blood (ASH Annual Meeting Abstracts), November 16, 2008; 112(11): 1639 - 1639.
[Abstract]


Home page
Cancer Res.Home page
C. L. Nguyen, M. E. McLaughlin-Drubin, and K. Munger
Delocalization of the Microtubule Motor Dynein from Mitotic Spindles by the Human Papillomavirus E7 Oncoprotein Is Not Sufficient for Induction of Multipolar Mitoses
Cancer Res., November 1, 2008; 68(21): 8715 - 8722.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
M. Kwon, S. A. Godinho, N. S. Chandhok, N. J. Ganem, A. Azioune, M. Thery, and D. Pellman
Mechanisms to suppress multipolar divisions in cancer cells with extra centrosomes
Genes & Dev., August 15, 2008; 22(16): 2189 - 2203.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2007 by the American Association for Cancer Research.